AAPS J 润色咨询

AAPS Journal

出版年份：2004 年文章数：1674 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：6.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2019-03-01 ms5109743545865402

    凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。
    但我会继续努力，下一个课题还要投它试一试

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2016-11-10 jz126

    此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-12-25 ms7657656453231030

    审稿速度:1.0
    经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-10-14 匿名用户

    不错的药学类杂志 ：）

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-05-25 ms9051856686409430

    5月7日投稿
    5月10日under review
    5月25日 required review completed
    审稿好快，不知道是不是不详的预兆，祈祷之中。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-02-02 ms5663569584175544

    此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=849999, encodeId=5c0a849999bb, content=凌晨3点钟投稿，第二天早上7点钟收到拒稿通知，来不及悲伤。<br> 但我会继续努力，下一个课题还要投它试一试 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0175414027, createdName=ms5109743545865402, createdTime=Fri Mar 01 20:53:30 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529202, encodeId=2c1752920210, content=此杂志现在的主编十个美籍香港人，似乎对大陆人不太友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c7e1979146, createdName=jz126, createdTime=Thu Nov 10 23:03:00 CST 2016, time=2016-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=830078, encodeId=5e198300e83c, content=审稿速度:1.0<br>经验分享：这是一个药学综合性期刊，涵盖药理学、药剂学、药物化学。审稿快，拒稿约75%。以前if5.9. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu Dec 25 22:18:13 CST 2014, time=2014-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=490992, encodeId=dac649099243, content=不错的药学类杂志 ：）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Oct 14 05:21:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=819663, encodeId=f9e481966383, content=5月7日投稿<br> 5月10日under review<br> 5月25日 required review completed<br> 审稿好快，不知道是不是不详的预兆，祈祷之中。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3d045413974, createdName=ms9051856686409430, createdTime=Fri May 25 09:01:00 CST 2012, time=2012-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817879, encodeId=c6ab81e87996, content=此杂志为美国aaps旗下三种杂志之一，相对于pharm res 来讲，其每年发表的文章总数较少，且很多为应邀综述类文章。但没有邀请也可以投稿，速度比较快，正常情况下大概一个月就会有结果。影响力个人觉得和pharm res差不多, 但后者发行量较大，知道的人更多一些。aaps j 和 pharm res上面的文章作者有药学背景者居多；同类杂志如j control release 和 mol pharm有不少文章都是化学、生物、材料等背景的作者发表的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23515414049, createdName=ms5663569584175544, createdTime=Thu Feb 02 22:28:00 CST 2012, time=2012-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481350, encodeId=ddf84813503a, content=看涨哦，如果明天再升一升，有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦，如果明天再升一升，有望突破3分

    0

共7条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分